Ripple CEO, Brad Garlinghouse hinted that the Ripple could file for an IPO as soon as by December 2020, Image  via Coindesk
Business

"In the next 12 months, many crypto companies will go public" - Brad Garlinghouse

Ripple CEO, Brad Garlinghouse hinted that the Ripple could file for an IPO as soon as by December 2020. Speaking at the World Economic Forum in Davos, Galinghouse mentioned that in the next 12 months you'll see a lot of crypto companies filing for IPOs, and I expect Ripple to be on the leading side as its a natural evolution for our company.

ceo blockchain ipo crypto ripple

Fri Jan 24 - Cointelegraph

Related Articles

His advice to those listening has been buying these assets and dumping the U.S Dollar.
Business
Rich Dad Poor Dad author predicts Bitcoin will reach $75,000 in 3 years

Rich Dad Poor Dad author, Kiyosaki has gone further to tag a price prediction for Bitcoin. He predicted that Bitcoin will reach $75,000 in the next three years. The author further confirmed that he is buying up some more Bitcoin seeing how incompetent the government has become. Kiyosaki’s prediction is conservative in comparison to other analysts like Anthony Pompliao and PlanB. These analysts expect Bitcoin to reach $100,000 in 2021.

technology finance crypto bitcoin cryptocurrencies

Sun May 17 - CryptoMute
Bitcoin hashrate has dropped violently and this will have an effect on prices.
Business
Bitcoin Hashrate Has Tanked 40% Since Halving; Bullish Or Bearish?

The latest data shows that miners are shutting down the mining equipment. Since the halving, there has been a 40% drop in hashrate. Arguably, just before the halving, this was at an all-time high with miners competing to grab as much as Bitcoin they could get while the reward was 12.5 BTC.

technology finance crypto bitcoin cryptocurrencies

Thu May 14 - CryptoMute
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now
Business
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now

Gilead Sciences priced its shares at $15 before its IPO. Still, though, a $10,000 investment in Gilead's IPO would now be worth nearly $1.8 million. Vistide was the beginning of a long and successful road for Gilead in treating HIV-related conditions. Gilead is also evaluating drugs that could potentially cure HIV in early stage clinical studies.

ipo drug gileads

Sun Apr 19 - Google
3M CEO tells Trump mask demand exceeds production capacity. Image via Wall Street Journal.
Business
3M CEO tells Trump mask demand too great

Mike Roman, the CEO of US-based mask and worker safety equipment manufacturing company 3M, has stated amid US President Donald Trump's invocation of the Defense Production Act that his company cannot meet the demand for masks in the country. Roman revealed that the industry only has the capacity to make 50 million N95 masks each month, while healthcare workers need 300 million to fight the coronavirus pandemic.

ceo donald-trump healthcare president safety equipment united-states manufacturing coronavirus pandemic covid-19 defense-production-act mike-roman 3m n95

Fri Apr 03 - Marketwatch